Cardiovascular Journal of Africa: Vol 30 No 2 (March/April 2019)

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 2, March/April 2019

AFRICA

Hamidi S, Akinci F. Measuring Efficiency of Health Systems of the

Middle East and North Africa (MENA) Region Using Stochastic

Frontier Analysis.

Appl Health Econ Health Policy

2016;

(3): 337–347.

DOI: 10.1007/s40258-016-0230-9.

Galal OM. The nutrition transition in Egypt: obesity, undernutrition

and the food consumption context.

Public Health Nutr

2002;

(1A):

141–148. DOI: 10.1079/PHN2001286.

Majeed A, El-Sayed AA, Khoja T, Alshamsan R, Millett C, Rawaf S.

Diabetes in the Middle-East and North Africa: an update.

Diabetes Res

Clin Pract

2014;

103

(2): 218–222. DOI: 10.1016/j.diabres.2013.11.008.

GBD 2015 Risk Factors Collaborators. Global, regional, and national

comparative risk assessment of 79 behavioural, environmental and

occupational, and metabolic risks or clusters of risks, 1990-2015: a

systematic analysis for the Global Burden of Disease Study 2015.

Lancet

2016;

388

(10053): 1659–1724. DOI: 10.1016/S0140-6736(16)31679-8.

10. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ,

et al

. 2016 ESC/EAS guidelines for the management of dyslipidae-

mias: The Task Force for the Management of Dyslipidaemias of the

European Society of Cardiology (ESC) and European Atherosclerosis

Society (EAS) Developed with the special contribution of the European

Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).

Atherosclerosis

2016;

253

: 281–344. DOI: 10.1016/j.atherosclero-

sis.2016.08.018.

11. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard

HW,

et al

. AmericanAssociation of Clinical Endocrinologists’Guidelines

for Management of Dyslipidemia and Prevention of Atherosclerosis.

Endocr Pract

2012;

(Suppl 1): 1–78. PMID: 22522068.

12. Wakabayashi I. Necessity of both waist circumference and waist-to-

height ratio for better evaluation of central obesity.

Metab Syndr Relat

Disord

2013;

(3): 189–194. DOI: 10.1089/met.2012.0131.

13. GBD 2015 Eastern Mediterranean Region Cardiovascular Disease

Collaborators. Burden of cardiovascular diseases in the Eastern

Mediterranean Region, 1990–2015: findings from the Global Burden

of Disease 2015 study.

Int J Public Health

2018;

(Suppl 1): 137–149.

DOI: 10.1007/s00038-017-1012-3.

14. Uthman OA, Hartley L, Rees K, Taylor F, Ebrahim S, Clarke A.

Multiple risk factor interventions for primary prevention of cardiovascu-

lar disease in low- and middle-income countries.

Cochrane Database Syst

Rev

2015;

2015

(8): CD011163. DOI: 10.1002/14651858.CD011163.pub2.

15. World Helath Organisation. Cardiovascular diseases. Updated March

2013: Fact sheet N8317.

16. Mensah GA, Roth GA, Sampson UK, Moran AE, Feigin VL,

Forouzanfar MH,

et al.

Mortality from cardiovascular diseases in

sub-Saharan Africa, 1990-2013: a systematic analysis of data from the

Global Burden of Disease Study 2013.

Cardiovasc J Afr

2015;

Suppl): S6–10. DOI: 10.5830/CVJA-2015-036.

17. El-Menyar A, Zubaid M, Shehab A, Bulbanat B, Albustani N, Alenezi

et al

. Prevalence and impact of cardiovascular risk factors among

patients presenting with acute coronary syndrome in the middle East.

Clin Cardiol

2011;

(1): 51–58. DOI: 10.1002/clc.20873.

18. Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore

JM,

et al

. The expanded Global Registry of Acute Coronary Events:

baseline characteristics, management practices, and hospital outcomes

of patients with acute coronary syndromes.

Am Heart J

2009;

158

(2):

193–201. e1-5. DOI: 10.1016/j.ahj.2009.06.003.

19. Mendis S, Davis S, Norrving B. Organizational update: the world health

organization global status report on noncommunicable diseases 2014; one

more landmark step in the combat against stroke and vascular disease.

Stroke

2015;

(5): e121-2. DOI: 10.1161/STROKEAHA.115.008097.

20. Caleyachetty R, Thomas GN, Toulis KA, Mohammed N, Gokhale

KM, Balachandran K,

et al

. Metabolically healthy obese and incident

cardiovascular disease events among 3.5 million men and women.

J Am

Coll Cardiol

2017;

(12): 1429–1437. DOI: 10.1016/j.jacc.2017.07.763.

21. Raal FJ, Alsheikh-Ali AA, Omar MI, Rashed W, Hamoui O, Kane

et al

. Cardiovascular risk factor burden in Africa and the Middle

East across country income categories: a

post hoc

analysis of the cross-

sectional Africa Middle East Cardiovascular Epidemiological (ACE)

study.

Arch Public Health

2018;

: 15. DOI: 10.1186/s13690-018-0257-5.

22. Hwang YC, Fujimoto WY, Hayashi T, Kahn SE, Leonetti DL, Boyko

EJ. Increased visceral adipose tissue is an independent predictor for

future development of atherogenic dyslipidemia.

J Clin Endocrinol

Metab

2016;

101

(2): 678–685. DOI: 10.1210/jc.2015-3246.

23. Arca M, Montali A, Valiante S, Campagna F, Pigna G, Paoletti V,

. Usefulness of atherogenic dyslipidemia for predicting cardiovas-

cular risk in patients with angiographically defined coronary artery

disease.

Am J Cardiol

2007;

100

(10): 1511–1516. DOI: 10.1016/j.

amjcard.2007.06.049.

24. Page JH, Rexrode KM, Hu F, Albert CM, Chae CU, Manson

JE. Waist-height ratio as a predictor of coronary heart disease

among women.

Epidemiology

2009;

(3): 361–366. DOI: 10.1097/

EDE.0b013e31819f38f1.

25. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screen-

ing tool than waist circumference and BMI for adult cardiometabolic

risk factors: systematic review and meta-analysis.

Obes Rev

2012;

(3):

275–286. DOI: 10.1111/j.1467-789X.2011.00952.x.

26. Savva SC, Lamnisos D, Kafatos AG. Predicting cardiometabolic risk:

waist-to-height ratio or BMI. A meta-analysis.

Diabetes Metab Syndr

Obes

2013;

: 403–419. DOI: 10.2147/DMSO.S34220.

27. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U,

Guariguata L, Cho NH,

et al

. IDF diabetes atlas: Global estimates for

the prevalence of diabetes for 2015 and 2040.

Diabetes Res Clin Pract

2017;

128

: 40–50. DOI: 10.1016/j.diabres.2017.03.024.

28. Pristipino C, Pelliccia F, Granatelli A, Pasceri V, Roncella A, Speciale

et al.

Comparison of access-related bleeding complications in women

versus men undergoing percutaneous coronary catheterization using the

radial versus femoral artery.

Am J Cardiol

2007;

(9): 1216–1221. DOI:

10.1016/j.amjcard.2006.12.038.

29. Plourde G, Bertrand OF. Radial access in women for percutaneous coro-

nary intervention: toward the end of the sex paradox?

J Am Coll Cardiol

Cardiovasc Interv

2018;

(1): 51–52. DOI: 10.1016/j.jcin.2017.10.025.

30. Porto I, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay JF,

. Impact of access site on bleeding and ischemic events in patients with

non-ST-segment elevation myocardial infarction treated with prasugrel:

The ACCOAST Access substudy.

J Am Coll Cardiol Cardiovasc Interv

2016;

(9): 897–907. DOI: 10.1016/j.jcin.2016.01.041.

31. Poon S, Goodman SG, Yan RT, Bugiardini R, Bierman AS, Eagle KA,

et al

. Bridging the gender gap: Insights from a contemporary analysis

of sex-related differences in the treatment and outcomes of patients

with acute coronary syndromes.

Am Heart J

2012;

163

(1): 66–73. DOI:

10.1016/j.ahj.2011.09.025.

32. Tamis-Holland JE, Palazzo A, Stebbins AL, Slater JN, Boland J, Ellis

SG,

et al.

Benefits of direct angioplasty for women and men with acute

myocardial infarction: results of the Global Use of Strategies to Open

Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO

II-B) Angioplasty substudy.

Am Heart J

2004;

147

(1): 133–139. PMID:

14691431.

33. Glaser R, Herrmann HC, Murphy SA, Demopoulos LA, DiBattiste

PM, Cannon CP,

et al

. Benefit of an early invasive management strat-

egy in women with acute coronary syndromes.

J Am Med Assoc

2002;

288

(24): 3124–3129. PMID: 12495392.